Targeting HCV Entry For Development of Therapeutics

Recent progress in defining the molecular mechanisms of Hepatitis C Virus (HCV) entry affords the opportunity to exploit new viral and host targets for therapeutic intervention. Entry inhibitors would limit the expansion of the infected cell reservoir, and would complement the many replication inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong-Staal, Flossie, Syder, Andrew J., McKelvy, Jeffrey F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185726/
https://www.ncbi.nlm.nih.gov/pubmed/21994703
http://dx.doi.org/10.3390/v2081718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185726/
https://www.ncbi.nlm.nih.gov/pubmed/21994703
http://dx.doi.org/10.3390/v2081718

Ejemplares similares